![Hong Yun Zhang](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Hong Yun Zhang
Director/Miembro de la Junta en Changzhou Biowin Pharmaceutical Co., Ltd. .
Fortuna: 4 M $ al 31/05/2024
Perfil
Hong Yun Zhang has a current job as a Member-Supervisory Board at Changzhou Biowin Pharmaceutical Co., Ltd.
Participaciones conocidas en empresas públicas
Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
---|---|---|---|---|
04/12/2023 | 60 000 000 ( 9.42% ) | 4 M $ | 31/05/2024 |
Cargos activos de Hong Yun Zhang
Empresas | Cargo | Inicio |
---|---|---|
Changzhou Biowin Pharmaceutical Co., Ltd.
![]() Changzhou Biowin Pharmaceutical Co., Ltd. Medical SpecialtiesHealth Technology Changzhou Biowin Pharmaceutical Co., Ltd. engages in the research, development, manufacture, and distribution of point-of-care diagnostic test kits (POCT). Its products include vitro diagnostic tools, Chinese patents and related applications for treating heart disease, infectious diseases, stroke, kidney function, diabetes, cancer, and bone metabolism disorders. The company also operates research laboratory, technology platforms, and response system for the development of emergency-use diagnostic product. Changzhou Biowin Pharmaceutical was founded on November 22, 2011 and is headquartered in Changzhou, China. | Director/Miembro de la Junta | - |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas privadas | 1 |
---|---|
Changzhou Biowin Pharmaceutical Co., Ltd.
![]() Changzhou Biowin Pharmaceutical Co., Ltd. Medical SpecialtiesHealth Technology Changzhou Biowin Pharmaceutical Co., Ltd. engages in the research, development, manufacture, and distribution of point-of-care diagnostic test kits (POCT). Its products include vitro diagnostic tools, Chinese patents and related applications for treating heart disease, infectious diseases, stroke, kidney function, diabetes, cancer, and bone metabolism disorders. The company also operates research laboratory, technology platforms, and response system for the development of emergency-use diagnostic product. Changzhou Biowin Pharmaceutical was founded on November 22, 2011 and is headquartered in Changzhou, China. | Health Technology |
- Bolsa de valores
- Insiders
- Hong Yun Zhang